MarketsandMarketsâ„¢ projects the global high-throughput screening (HTS) market will grow from USD 27.66 billion in 2026 to USD ...
Molecular Devices developed an end-to-end, automated workflow, beginning with assay-ready colorectal cancer organoids, comprising establishment in culture, maintenance, and screening. Automation ...
Discover how the next generation of DMTA is creating a future-ready drug discovery engine through AI and automation.
Revvity, Inc. today announced the development of the T-SPOTâ„¢ A201, a next-generation high-throughput automated platform ...
High-throughput screening (HTS) is a cornerstone of modern drug discovery, enabling the evaluation of thousands to millions of potential drug compounds. Advances in automation and miniaturization have ...
The U.S. Life Science Tools Market is projected to grow from USD 68.50 Billion in 2025 to USD 189.48 Billion by 2035, while ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results